Corey E. Bienstock
12Patents
7h-index
76Co-inventors
61Inventor score
Filing activity: Jun 22, 2011 → Feb 8, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9556168B2 | N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 16 | Active |
| US9663502B2 | 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease | Chemistry; Metallurgy | 12 | Active |
| US9783511B2 | Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 9 | Active |
| US9809561B2 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 8 | Active |
| US9745265B2 | 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 8 | Active |
| US9145391B2 | Bipyridylaminopyridines as Syk inhibitors | Chemistry; Metallurgy | 8 | Active |
| US9216173B2 | 2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors | Chemistry; Metallurgy | 8 | Active |
| US10221146B2 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 6 | Active |
| US9023865B2 | Compounds that are ERK inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10196354B2 | 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US10745364B2 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US8999957B2 | Heterocyclic compounds as ERK inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.